Registry Study for Radiation Therapy Outcomes
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy
1 other identifier
observational
40,000
1 country
29
Brief Summary
The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
29 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 6, 2010
CompletedFirst Posted
Study publicly available on registry
December 7, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2039
ExpectedSeptember 9, 2025
September 1, 2025
30 years
December 6, 2010
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Define outcomes for patients treated at participating institutions
PRN
Secondary Outcomes (2)
Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures
Annually PRN
Improve patient care by an adequate understanding of the results and patient population at participating institutions
Reviewed Annually PRN
Study Arms (1)
Treatment with Radiation Therapy
Includes 16 different arms to capture patient data by disease site
Interventions
Outcomes Tracking
Eligibility Criteria
Radiation Oncology patients
You may qualify if:
- Planned treatment with radiation therapy
- Ability to understand and sign IRB approved consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (29)
Mayo Clinic
Scottsdale, Arizona, 85259-5499, United States
Proton Center of Arkansas
Little Rock, Arkansas, 72205, United States
California Protons Cancer Therapy Center
San Diego, California, 92121, United States
South Florida Proton Therapy Institute
Delray Beach, Florida, 33484, United States
Ackerman Cancer Center
Jacksonville, Florida, 32223, United States
Dwoskin Proton Therapy Center
Miami, Florida, 33125, United States
Miami Cancer Institute
Miami, Florida, 33176, United States
Orlando Health Cancer Institute
Orlando, Florida, 32806, United States
Emory Proton Therapy Center
Atlanta, Georgia, 30308, United States
OSF HealthCare Cancer Institute
Peoria, Illinois, 61603, United States
Northwestern Medicine Chicago Proton Center
Warrenville, Illinois, 60555, United States
University of Kansas Proton Therapy Center
Kansas City, Kansas, 66160, United States
Kansas City Proton Institute
Overland Park, Kansas, 66207, United States
Willis-Knighton Cancer and Proton Therapy Center
Shreveport, Louisiana, 71103, United States
Maryland Proton Treatment Center
Baltimore, Maryland, 21201, United States
McLaren Proton Therapy Center
Flint, Michigan, 48532, United States
Washington University in St. Louis
St Louis, Missouri, 63110, United States
Mercy David C. Pratt Cancer Center
St Louis, Missouri, 63141, United States
ProCure Proton Therapy Center
Somerset, New Jersey, 08873, United States
New York Proton Center
New York, New York, 10035, United States
Atrium Health Levine Cancer Proton & Advanced Radiation Center
Charlotte, North Carolina, 28204, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, 45044, United States
Oklahoma Proton Center
Oklahoma City, Oklahoma, 73142, United States
Tennessee Oncology Proton Center
Franklin, Tennessee, 37067, United States
Thompson Proton Center
Knoxville, Tennessee, 37909, United States
Texas Center for Proton Therapy
Irving, Texas, 75063, United States
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
Hampton University Proton Therapy Institute
Hampton, Virginia, 23666, United States
University of Washington
Seattle, Washington, 98195-6043, United States
Related Publications (1)
Lee HJ Jr, Macomber MW, Spraker MB, Bowen SR, Hippe DS, Fung A, Russell KJ, Laramore GE, Rengan R, Liao J, Apisarnthanarax S, Zeng J. Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes. Radiat Oncol. 2018 Sep 17;13(1):179. doi: 10.1186/s13014-018-1127-6.
PMID: 30223877DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Carlos Vargas, MD
Proton Collaborative Group
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Years
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2010
First Posted
December 7, 2010
Study Start
June 1, 2009
Primary Completion (Estimated)
June 1, 2039
Last Updated
September 9, 2025
Record last verified: 2025-09